ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Other Working Capital Changes of $52.0 for Q1 2026, up 1633.33% year-over-year from $3.0 in Q1 2025, and up 100.04% quarter-over-quarter from -$139740.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Other Working Capital Changes data on file, last reported at $52.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $52.0, up 1633.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.0 (up 1633.33% YoY), and the FY2025 annual result was $42.0, up 7.69% from the prior year.
- Other Working Capital Changes climbed to $52.0 in Q1 2026 per NDRA's latest filing, from -$139740.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $47769.0 in Q2 2022 and troughed at -$286597.0 in Q1 2022.
- A 5-year average of -$43044.8 and a median of $38.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes slumped 756.87% in 2022, then jumped 1633.33% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at -$257481.0 in 2022, then rose by 24.42% to -$194608.0 in 2023, then surged by 84.61% to -$29941.0 in 2024, then plunged by 366.72% to -$139740.0 in 2025, then surged by 100.04% to $52.0 in 2026.
- Business Quant data shows NDRA's Other Working Capital Changes at $52.0 in Q1 2026, -$139740.0 in Q4 2025, and $12.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.00 |
| Mar 31, 2026 | 52.00 |
| Dec 31, 2025 | -139,740.00 |
| Dec 31, 2025 | -139,740.00 |
| Sep 30, 2025 | 12.00 |
| Sep 30, 2025 | 12.00 |
| Jun 30, 2025 | 12.00 |
| Jun 30, 2025 | 12.00 |
| Mar 31, 2025 | 3.00 |
| Mar 31, 2025 | 3.00 |
| Dec 31, 2024 | -29,941.00 |
| Dec 31, 2024 | -29,941.00 |
| Sep 30, 2024 | 38.00 |
| Sep 30, 2024 | 38.00 |
| Jun 30, 2024 | 399.00 |
| Jun 30, 2024 | 399.00 |
| Mar 31, 2024 | 299.00 |
| Mar 31, 2024 | 299.00 |
| Dec 31, 2023 | -194,608.00 |
| Dec 31, 2023 | -194,608.00 |